Latest Neurodegenerative disease Stories
Regular exercise could help prevent brain damage associated with neurodegenerative diseases like Alzheimer's.
It's a chicken and egg question. Where do the infectious protein particles called prions come from?
ROCKVILLE, Md., July 21, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received a patent covering the transplantation of human neural cells for the treatment of neurodegenerative conditions from the Russian Federation.
MOUNT KILIMANJARO, Tanzania, July 18, 2011 /PRNewswire/ -- Today, seven adventurous men and women with Multiple Sclerosis (MS) and four with Parkinson's disease (PD), along with nine climbing companions, reached the highest peak in Africa.
Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.
Jeremy Smith, Governor's Chair for Molecular Biophysics at the University of Tennessee, Knoxville, has helped reveal a key trigger of Gerstmannâ€“StrÃ¤usslerâ€“Scheinker (GSS) syndrome, a rare but deadly neurodegenerative disease.
An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.
There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
TIMONIUM, Md., June 19, 2011 /PRNewswire/ -- An international team of researchers led by Gerard D.
NEW YORK, June 15, 2011 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
- totally perplexed and mixed up.